Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 202 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Africa | 202 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 306,670 |
| Germany | 73,127 |
| France | 73,097 |
| Italy | 48,361 |
| China | 45,791 |
| Japan | 38,701 |
| Spain | 36,382 |
| United Kingdom | 32,384 |
Trial sites
202 sites. Sites with a public page link to it on Pharma Observatory.
-
Ngange CS 1 trial
-
Nkanka CS 1 trial
-
Nkombo CS 1 trial
-
Nkungu CS 1 trial
-
Novartis Investigative Site 1 trial
-
Novartis Investigative Site 1 trial
-
Novartis Investigative Site 1 trial
-
Nyabihu District 1 trial
-
Nyabitimbo CS 1 trial
-
Nyagihamba Health Center 1 trial
-
Nyakabuye CS 1 trial
-
Nyakarenzo CS 1 trial
-
Nyamasheke CS 1 trial
-
Nyamata District Hospital 1 trial
-
Nyamata Hospital 1 trial
-
Nyamiyaga Health Center 1 trial
-
Partners In Health/Inshuti Mu Buzima (PIH/IMB) 1 trial
-
Partners in Health- Rwanda 1 trial
-
Plan International, Rwanda 1 trial
-
Programme Nationale Integre de Lutte contre le Paludisme 1 trial
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.